| Ticker Symbol: | OFIX |
|---|---|
| Exchange: | NASD |
| Contact Info: | 7 Abraham de Veerstraat Netherlands Antilles 59 99 465 8525 |
| CEO/President: | Alan W. Milinazzo |
| Industry: | Medical Products / Standard Industry Code: 3841 |
| Description: | Orthofix International N.V. is a leading provider of high-value, minimally invasive medical devices for the orthopaedic and trauma markets. Orthofix is well positioned to expand its focus and capitalise on the growing medical acceptance of high technology in orthopaedic treatment and spine repair. The company sells its diverse product line in different countries through its subsidiaries and distribution agreements with leading orthopaedic companies, including Sulzer Medica Group, Sofamor DanekGroup, Kendall Healthcare Products and B. Braun. (PRESS RELEASE) |
| Shares Outstanding: | 17,100 (000) | Market Value: | 204,710 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 96.29% | Number of Inst.Shareholders: | 5.00% |
| Last Quarter Sales: | 129.30 ($Mil.) | Last Quarter Net Income: | -237.25 ($Mil.) |
| Last Quarter EPS: | 0.34 | P/E Ratio: | 10 |
| Most Recent Earnings: | 0.02 on 11/06/08 | Earnings Per Share: | -13.94 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| BOSTON SCIENTIF | -54.40 | 5.91 | |
| MEDTRONIC INC | -52.60 | 28.67 | |
| BAXTER INTL INC | -21.20 | 51.48 | |
| ST. JUDE MEDICA | -41.00 | 26.80 | |
| STRYKER CP | -57.60 | 36.84 |
